BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26849011)

  • 41. Early deaths in pediatric acute leukemia: a population-based study.
    Cheng S; Pole JD; Sung L
    Leuk Lymphoma; 2014 Jul; 55(7):1518-22. PubMed ID: 24090501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fetal growth and childhood cancer: a population-based study.
    Bjørge T; Sørensen HT; Grotmol T; Engeland A; Stephansson O; Gissler M; Tretli S; Troisi R
    Pediatrics; 2013 Nov; 132(5):e1265-75. PubMed ID: 24167169
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in survival of leukemia among children, adolescents, and young adults: A population-based study in Osaka, Japan.
    Nakata K; Okawa S; Fuji S; Sato A; Morishima T; Tada Y; Inoue M; Hara J; Kawa K; Miyashiro I;
    Cancer Sci; 2021 Mar; 112(3):1150-1160. PubMed ID: 33428808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America.
    Karalexi MA; Baka M; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Demetriou A; Agius D; Florea M; Coza D; Polychronopoulou S; Stiakaki E; Moschovi M; Hatzipantelis E; Kourti M; Graphakos S; Pombo-de-Oliveira MS; Adami HO; Petridou ET
    Eur J Cancer; 2016 Nov; 67():183-190. PubMed ID: 27677054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Loss in Expectation of Life due to Early-Onset Mild Cognitive Impairment and Early-Onset Dementia in Norway.
    Strand BH; Knapskog AB; Persson K; Holt Edwin T; Bjertness E; Engedal K; Selbaek G
    Dement Geriatr Cogn Disord; 2019; 47(4-6):355-365. PubMed ID: 31319412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The incidence and survival of acute de novo leukemias in Estonia and in a well-defined region of western Sweden during 1997-2001: a survey of patients aged >or=65 years.
    Palk K; Luik E; Varik M; Viigimaa I; Vaht K; Everaus H; Wennström L; Stockelberg D; Safai-Kutti S; Holmberg E; Kutti J
    Cancer Epidemiol; 2010 Feb; 34(1):24-8. PubMed ID: 20071253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Estimating expected survival probabilities for relative survival analysis--exploring the impact of including cancer patient mortality in the calculations.
    Talbäck M; Dickman PW
    Eur J Cancer; 2011 Nov; 47(17):2626-32. PubMed ID: 21924892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved outcome of childhood acute myeloid leukemia in an Eastern European country: Lithuanian experience.
    Kairiene I; Pasauliene R; Lipunova N; Vaitkeviciene G; Rageliene L; Rascon J
    Eur J Pediatr; 2017 Oct; 176(10):1329-1337. PubMed ID: 28812191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spatio-temporal Analysis of District-level Life Expectancy from 2004 to 2017 in Korea.
    Lim HK; Kang HY; Kim I; Khang YH
    J Korean Med Sci; 2021 Jan; 36(2):e8. PubMed ID: 33429472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mobile phones, cordless phones and rates of brain tumors in different age groups in the Swedish National Inpatient Register and the Swedish Cancer Register during 1998-2015.
    Hardell L; Carlberg M
    PLoS One; 2017; 12(10):e0185461. PubMed ID: 28976991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential survival improvement for patients 20-29 years of age with acute lymphoblastic leukemia.
    Pole JD; Darmawikarta D; Alibhai SM; Brandwein JM; Sung L
    Leuk Res; 2013 Oct; 37(10):1258-64. PubMed ID: 23867057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does minimum follow-up time post-diagnosis matter? An assessment of changing loss of life expectancy for people with cancer in Western Australia from 1982 to 2016.
    Wright CM; Moorin RE
    Cancer Epidemiol; 2020 Jun; 66():101705. PubMed ID: 32224327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Life expectancy and risk of death in 6791 communities in England from 2002 to 2019: high-resolution spatiotemporal analysis of civil registration data.
    Rashid T; Bennett JE; Paciorek CJ; Doyle Y; Pearson-Stuttard J; Flaxman S; Fecht D; Toledano MB; Li G; Daby HI; Johnson E; Davies B; Ezzati M
    Lancet Public Health; 2021 Nov; 6(11):e805-e816. PubMed ID: 34653419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary Acute Leukemia in Sarcoma Patients: A Population-Based Study.
    Sanford NN; Martin AM; Brunner AM; Cote GM; Choy E; DeLaney TF; Aizer AA; Chen YL
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):687-694. PubMed ID: 29413281
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000-2013.
    Beinortas T; Tavorienė I; Žvirblis T; Gerbutavičius R; Jurgutis M; Griškevičius L
    BMC Cancer; 2016 Mar; 16():198. PubMed ID: 26956037
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
    Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
    Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
    Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
    JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increase in the Life Expectancy of Patients with Cancer in the United States.
    Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex disparity in childhood and young adult acute myeloid leukemia (AML) survival: Evidence from US population data.
    Hossain MJ; Xie L
    Cancer Epidemiol; 2015 Dec; 39(6):892-900. PubMed ID: 26520618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Life expectancy as an indicator of outcome in follow-up of population-based cancer registries: the example of childhood leukemia.
    Viscomi S; Pastore G; Dama E; Zuccolo L; Pearce N; Merletti F; Magnani C
    Ann Oncol; 2006 Jan; 17(1):167-71. PubMed ID: 16249212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.